Different duration strategies of perioperative antibiotic prophylaxis in adult patients undergoing cardiac surgery: an observational study
Autor: | Hamouda, Khaled, Oezkur, Mehmet, Sinha, Bhanu, Hain, Johannes, Menkel, Hannah, Leistner, Marcus, Leyh, Rainer, Schimmer, Christoph |
---|---|
Přispěvatelé: | Microbes in Health and Disease (MHD), Critical care, Anesthesiology, Peri-operative and Emergency medicine (CAPE) |
Jazyk: | angličtina |
Rok vydání: | 2015 |
Předmět: |
Adult
Male PRACTICE GUIDELINE SERIES SOCIETY Perioperative Care Postoperative Complications Nosocomial infection Humans Surgical Wound Infection POSTOPERATIVE INFECTIONS Cardiac Surgical Procedures Antibiotic prophylaxis METAANALYSIS Aged Retrospective Studies Cross Infection ddc:617 NOSOCOMIAL INFECTIONS Middle Aged Cardiac surgery PREVENTION Anti-Bacterial Agents Cephalosporins SEVERE SEPSIS BYPASS HEART-SURGERY Female Surgery Cardiology and Cardiovascular Medicine Research Article |
Zdroj: | Journal of cardiothoracic surgery, 10:25. BMC Journal of Cardiothoracic Surgery |
ISSN: | 1749-8090 |
Popis: | Background All international guidelines recommend perioperative antibiotic prophylaxis (PAB) should be routinely administered to patients undergoing cardiac surgery. However, the duration of PAB is heterogeneous and controversial. Methods Between 01.01.2011 and 31.12.2011, 1096 consecutive cardiac surgery patients were assigned to one of two groups receiving PAB with a second-generation cephalosporin for either 56 h (group I) or 32 h (group II). Patients’ characteristics, intraoperative data, and the in-hospital follow-up were analysed. Primary endpoint was the incidence of surgical site infection (deep and superficial sternal wound-, and vein harvesting site infection; DSWI/SSWI/VHSI). Secondary endpoints were the incidence of respiratory-, and urinary tract infection, as well as the mortality rate. Results 615/1096 patients (56,1%) were enrolled (group I: n = 283 versus group II: n = 332). There were no significant differences with regard to patient characteristics, comorbidities, and procedure-related variables. No statistically significant differences were demonstrated concerning primary and secondary endpoints. The incidence of DSWI/SSWI/VHSI were 4/283 (1,4%), 5/283 (1,7%), and 1/283 (0,3%) in group I versus 6/332 (1,8%), 9/332 (2,7%), and 3/332 (0,9%) in group II (p = 0,76/0,59/0,63). In univariate analyses female gender, age, peripheral arterial obstructive disease, operating-time, ICU-duration, transfusion, and respiratory insufficiency were determinants for nosocomial infections (all ≤ 0,05). Subgroup analyses of these high-risk patients did not show any differences between the two regimes (all ≥ 0,05). Conclusions Reducing the duration of PAB from 56 h to 32 h in adult cardiac surgery patients was not associated with an increase of nosocomial infection rate, but contributes to reduce antibiotic resistance and health care costs. |
Databáze: | OpenAIRE |
Externí odkaz: |